PURPOSE: Systematic review comparing biological agents, targeting tumour necrosis factor α, for sciatica with placebo and alternative interventions. METHODS: We searched 21 electronic databases and bibliographies of included studies. We included randomised controlled trials (RCTs), non-RCTs and controlled observational studies of adults who had sciatica treated by biological agents compared with placebo or alternative interventions. RESULTS: We pooled the results of six studies (five RCTs and one non-RCT) in meta-analyses. Compared with placebo biological agents had: better global effects in the short-term odds ratio (OR) 2.0 (95 % CI 0.7-6.0), medium-term OR 2.7 (95 % CI 1.0-7.1) and long-term OR 2.3 [95 % CI 0.5 to 9.7); improved leg pain intensity in the short-term weighted mean difference (WMD) -13.6 (95 % CI -26.8 to -0.4), medium-term WMD -7.0 (95 % CI -15.4 to 1.5), but not long-term WMD 0.2 (95 % CI -20.3 to 20.8); improved Oswestry Disability Index (ODI) in the short-term WMD -5.2 (95 % CI -14.1 to 3.7), medium-term WMD -8.2 (95 % CI -14.4 to -2.0), and long-term WMD -5.0 (95 % CI -11.8 to 1.8). There was heterogeneity in the leg pain intensity and ODI results and improvements were no longer statistically significant when studies were restricted to RCTs. There was a reduction in the need for discectomy, which was not statistically significant, and no difference in the number of adverse effects. CONCLUSIONS: There was insufficient evidence to recommend these agents when treating sciatica, but sufficient evidence to suggest that larger RCTs are needed.
PURPOSE: Systematic review comparing biological agents, targeting tumour necrosis factor α, for sciatica with placebo and alternative interventions. METHODS: We searched 21 electronic databases and bibliographies of included studies. We included randomised controlled trials (RCTs), non-RCTs and controlled observational studies of adults who had sciatica treated by biological agents compared with placebo or alternative interventions. RESULTS: We pooled the results of six studies (five RCTs and one non-RCT) in meta-analyses. Compared with placebo biological agents had: better global effects in the short-term odds ratio (OR) 2.0 (95 % CI 0.7-6.0), medium-term OR 2.7 (95 % CI 1.0-7.1) and long-term OR 2.3 [95 % CI 0.5 to 9.7); improved leg pain intensity in the short-term weighted mean difference (WMD) -13.6 (95 % CI -26.8 to -0.4), medium-term WMD -7.0 (95 % CI -15.4 to 1.5), but not long-term WMD 0.2 (95 % CI -20.3 to 20.8); improved Oswestry Disability Index (ODI) in the short-term WMD -5.2 (95 % CI -14.1 to 3.7), medium-term WMD -8.2 (95 % CI -14.4 to -2.0), and long-term WMD -5.0 (95 % CI -11.8 to 1.8). There was heterogeneity in the leg pain intensity and ODI results and improvements were no longer statistically significant when studies were restricted to RCTs. There was a reduction in the need for discectomy, which was not statistically significant, and no difference in the number of adverse effects. CONCLUSIONS: There was insufficient evidence to recommend these agents when treating sciatica, but sufficient evidence to suggest that larger RCTs are needed.
Authors: Erin D Milligan; Evan M Sloane; Stephen J Langer; Travis S Hughes; Brian M Jekich; Matthew G Frank; John H Mahoney; Lindsay H Levkoff; Steven F Maier; Pedro E Cruz; Terence R Flotte; Kirk W Johnson; Melissa M Mahoney; Raymond A Chavez; Leslie A Leinwand; Linda R Watkins Journal: Pain Date: 2006-09-01 Impact factor: 6.961
Authors: Timo Korhonen; Jaro Karppinen; Leena Paimela; Antti Malmivaara; Karl-August Lindgren; Chris Bowman; Anthony Hammond; Bruce Kirkham; Simo Järvinen; Jaakko Niinimäki; Nic Veeger; Marianne Haapea; Markus Torkki; Osmo Tervonen; Seppo Seitsalo; Heikki Hurri Journal: Spine (Phila Pa 1976) Date: 2006-11-15 Impact factor: 3.468
Authors: Jaro Karppinen; Timo Korhonen; Antti Malmivaara; Leena Paimela; Eero Kyllönen; Karl-August Lindgren; Pekka Rantanen; Osmo Tervonen; Jaakko Niinimäki; Seppo Seitsalo; Heikki Hurri Journal: Spine (Phila Pa 1976) Date: 2003-04-15 Impact factor: 3.468
Authors: Steven P Cohen; Ronald L White; Connie Kurihara; Thomas M Larkin; Audrey Chang; Scott R Griffith; Christopher Gilligan; Ralph Larkin; Benny Morlando; Paul F Pasquina; Tony L Yaksh; Conner Nguyen Journal: Ann Intern Med Date: 2012-04-17 Impact factor: 51.598
Authors: Kathryn T Weber; Timothy D Jacobsen; Robert Maidhof; Justin Virojanapa; Chris Overby; Ona Bloom; Shaheda Quraishi; Mitchell Levine; Nadeen O Chahine Journal: Curr Rev Musculoskelet Med Date: 2015-03